How to Be Sure It's B2: Three Steps to Life-Changing Intervention

This content was provided by Boehringer Ingelheim. Clinician's Brief was not involved with its creation.

Accurately staging patients with myxomatous mitral valve disease is critical to ensuring appropriate treatment to help achieve the best possible outcome for these patients.

In this article, get tips for how to properly stage these patients. Click here to read it now.